Home
Conditions
Infectious Encephalitis

Clinical trial condition

Infectious Encephalitis

Explore clinical trials studying Infectious Encephalitis. Study availability and eligibility vary by location and protocol.

147 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Infectious Encephalitis trial results

Completed

VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults

NCT03879603

Conditions: Alphavirus Infections, Arbovirus Infections, Brain Diseases, +23 more
Locations: The Hope Clinic of the Emory Vaccine Center Decatur, Georgia, United States

View Trial Details

Completed

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

NCT02318069

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Dept infectious diseases Helsinki, Finland

Dept infectious diseases Eskilstuna, Sweden

View Trial Details

Completed

TBE Seropersistence up to 10 Years After First Booster in Adults

NCT01582698

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Prywatny Gabinet Lekarski Dębica, Poland

"John Paul II" Cracow Specialist Hospital, Department of Pediatric Neuroinfections and Neurology Krakow, Poland

View Trial Details

Completed

Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose

NCT02514746

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

NCT02880865

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +30 more
Locations: Research Institute for Tropical Medicine Manila, Philippines

View Trial Details

Completed

Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis

NCT01981161

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +19 more
Locations: CHU Besançon Besançon, France

CHU Bordeaux Bordeaux, France

CHU Caen Caen, France

Chu Lille Lille, France

View Trial Details

Completed

Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects

NCT04131595

Conditions: Alphavirus Infections, Arbovirus Infections, Brain Diseases, +18 more
Locations: Johnson County Clin-Trials Lenexa, Kansas, United States

View Trial Details

Completed

Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine

NCT00463476

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Homagama MOH Division Medical Office Homagama, District of Colombo, Sri Lanka

Kolonnawa MOH Division Medical Office Kolonnawa, District of Colombo, Sri Lanka

Moratuwa MOH Division Medical Office Moratuwa, District of Colombo, Sri Lanka

View Trial Details

Completed

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

NCT01246479

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Tampa, Florida, United States

Brisbane, Australia

Melbourne, Australia

Berlin, Germany

View Trial Details

Completed

Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine

NCT02654509

Conditions: Alphavirus Infections, Arbovirus Infections, Brain Diseases, +19 more
Locations: Special Immunizations Program, Division of Medicine, USAMRIID Fort Deterick, Maryland, United States

View Trial Details

Infectious Encephalitis

Infectious Encephalitis trial results

Related conditions